Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
4,197
archived clinical trials in
Atrial Fibrillation

Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated:  12/31/1969
Boise Kidney and Hypertension Institute
mi
from
Meridian, ID
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated: 12/31/1969
Boise Kidney and Hypertension Institute
mi
from
Meridian, ID
Click here to add this to my saved trials
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated:  12/31/1969
Northwestern University
mi
from
Chicago, IL
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated: 12/31/1969
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated:  12/31/1969
NANI Research
mi
from
Crystal Lake, IL
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated: 12/31/1969
NANI Research
mi
from
Crystal Lake, IL
Click here to add this to my saved trials
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated:  12/31/1969
NANI Research
mi
from
River Forest, IL
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated: 12/31/1969
NANI Research
mi
from
River Forest, IL
Click here to add this to my saved trials
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated:  12/31/1969
NANI Research
mi
from
Fort Wayne, IN
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated: 12/31/1969
NANI Research
mi
from
Fort Wayne, IN
Click here to add this to my saved trials
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated:  12/31/1969
Northwest Louisiana Nephrology
mi
from
Shreveport, LA
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated: 12/31/1969
Northwest Louisiana Nephrology
mi
from
Shreveport, LA
Click here to add this to my saved trials
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated:  12/31/1969
Anne Arundel Medical Center
mi
from
Annapolis, MD
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated: 12/31/1969
Anne Arundel Medical Center
mi
from
Annapolis, MD
Click here to add this to my saved trials
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins University
mi
from
Baltimore, MD
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated:  12/31/1969
Washington Nephrology Associates
mi
from
Takoma Park, MD
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated: 12/31/1969
Washington Nephrology Associates
mi
from
Takoma Park, MD
Click here to add this to my saved trials
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated:  12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated: 12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated:  12/31/1969
South Shore Nephrology, P.C.
mi
from
Plymouth, MA
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated: 12/31/1969
South Shore Nephrology, P.C.
mi
from
Plymouth, MA
Click here to add this to my saved trials
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated:  12/31/1969
Renal and Transplant Associates of New England, PC
mi
from
Springfield, MA
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated: 12/31/1969
Renal and Transplant Associates of New England, PC
mi
from
Springfield, MA
Click here to add this to my saved trials
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated:  12/31/1969
Paragon Health Neprhology Centre
mi
from
Kalamazoo, MI
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated: 12/31/1969
Paragon Health Neprhology Centre
mi
from
Kalamazoo, MI
Click here to add this to my saved trials
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated:  12/31/1969
St. Clair Nephrology
mi
from
Port Huron, MI
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated: 12/31/1969
St. Clair Nephrology
mi
from
Port Huron, MI
Click here to add this to my saved trials
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated:  12/31/1969
The Mayo Clinic
mi
from
Rochester, MN
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated: 12/31/1969
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated:  12/31/1969
Southwest Mississippi Nephrology, PLLC
mi
from
Brookhaven, MS
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated: 12/31/1969
Southwest Mississippi Nephrology, PLLC
mi
from
Brookhaven, MS
Click here to add this to my saved trials
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated:  12/31/1969
Southern Clinical Research Group, LLC
mi
from
Gulfport, MS
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated: 12/31/1969
Southern Clinical Research Group, LLC
mi
from
Gulfport, MS
Click here to add this to my saved trials
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated:  12/31/1969
Nephrology and Hypertension Associates, LTD
mi
from
Tupelo, MS
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated: 12/31/1969
Nephrology and Hypertension Associates, LTD
mi
from
Tupelo, MS
Click here to add this to my saved trials
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated:  12/31/1969
Polack Renal, LLC
mi
from
Saint Louis, MO
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated: 12/31/1969
Polack Renal, LLC
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated:  12/31/1969
Sierra Nevada Nephrology Consultants
mi
from
Reno, NV
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated: 12/31/1969
Sierra Nevada Nephrology Consultants
mi
from
Reno, NV
Click here to add this to my saved trials
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated:  12/31/1969
Renal Medicine Associates
mi
from
Albuquerque, NM
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated: 12/31/1969
Renal Medicine Associates
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated:  12/31/1969
Advanced Kidney Care of Hudson Valley
mi
from
Poughkeepsie, NY
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated: 12/31/1969
Advanced Kidney Care of Hudson Valley
mi
from
Poughkeepsie, NY
Click here to add this to my saved trials
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated:  12/31/1969
Durham Nephrology Associates
mi
from
Durham, NC
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated: 12/31/1969
Durham Nephrology Associates
mi
from
Durham, NC
Click here to add this to my saved trials
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated:  12/31/1969
East Carolina University
mi
from
Greenville, NC
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated: 12/31/1969
East Carolina University
mi
from
Greenville, NC
Click here to add this to my saved trials
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated:  12/31/1969
Eastern Nephrology Associates
mi
from
Kinston, NC
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated: 12/31/1969
Eastern Nephrology Associates
mi
from
Kinston, NC
Click here to add this to my saved trials
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated:  12/31/1969
Eastern Nephrology Associates, PLLC
mi
from
New Bern, NC
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated: 12/31/1969
Eastern Nephrology Associates, PLLC
mi
from
New Bern, NC
Click here to add this to my saved trials
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated:  12/31/1969
HNC Dialysis Ltd.
mi
from
Columbus, OH
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated: 12/31/1969
HNC Dialysis Ltd.
mi
from
Columbus, OH
Click here to add this to my saved trials
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated:  12/31/1969
Northeast Clinical Research Center, LLC
mi
from
Bethlehem, PA
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated: 12/31/1969
Northeast Clinical Research Center, LLC
mi
from
Bethlehem, PA
Click here to add this to my saved trials
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated:  12/31/1969
Penn State Health Milton S. Hershey Medical Center
mi
from
Hershey, PA
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated: 12/31/1969
Penn State Health Milton S. Hershey Medical Center
mi
from
Hershey, PA
Click here to add this to my saved trials
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated:  12/31/1969
Rhode Island Hospital
mi
from
Providence, RI
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated: 12/31/1969
Rhode Island Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated:  12/31/1969
Columbia Nephrology Associates
mi
from
Columbia, SC
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated: 12/31/1969
Columbia Nephrology Associates
mi
from
Columbia, SC
Click here to add this to my saved trials
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated:  12/31/1969
South Carolina Nephrology & Hypertension
mi
from
Orangeburg, SC
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated: 12/31/1969
South Carolina Nephrology & Hypertension
mi
from
Orangeburg, SC
Click here to add this to my saved trials
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated:  12/31/1969
Sumter Medical Specialists
mi
from
Sumter, SC
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated: 12/31/1969
Sumter Medical Specialists
mi
from
Sumter, SC
Click here to add this to my saved trials
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated:  12/31/1969
Regional Health Clinical Research
mi
from
Rapid City, SD
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated: 12/31/1969
Regional Health Clinical Research
mi
from
Rapid City, SD
Click here to add this to my saved trials
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated:  12/31/1969
Knoxville Kidney Center PLLC
mi
from
Knoxville, TN
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated: 12/31/1969
Knoxville Kidney Center PLLC
mi
from
Knoxville, TN
Click here to add this to my saved trials
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated:  12/31/1969
Southwest Houston Research, Ltd
mi
from
Houston, TX
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated: 12/31/1969
Southwest Houston Research, Ltd
mi
from
Houston, TX
Click here to add this to my saved trials
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated:  12/31/1969
Lubbock Vascular Access Center
mi
from
Lubbock, TX
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated: 12/31/1969
Lubbock Vascular Access Center
mi
from
Lubbock, TX
Click here to add this to my saved trials
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated:  12/31/1969
University of Utah
mi
from
Salt Lake City, UT
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated: 12/31/1969
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated:  12/31/1969
Washington Nephrology Associates
mi
from
Alexandria, VA
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated: 12/31/1969
Washington Nephrology Associates
mi
from
Alexandria, VA
Click here to add this to my saved trials
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated:  12/31/1969
University Of Virgina Health System
mi
from
Charlottesville, VA
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated: 12/31/1969
University Of Virgina Health System
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated:  12/31/1969
TPMG Clinical Research
mi
from
Newport News, VA
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated: 12/31/1969
TPMG Clinical Research
mi
from
Newport News, VA
Click here to add this to my saved trials
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated:  12/31/1969
Valley Nephrology Associates
mi
from
Roanoke, VA
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated: 12/31/1969
Valley Nephrology Associates
mi
from
Roanoke, VA
Click here to add this to my saved trials
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated:  12/31/1969
Univ of Washington
mi
from
Seattle, WA
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated: 12/31/1969
Univ of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated:  12/31/1969
Nephrology and Hypertension Associates
mi
from
Bluefield, WV
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated: 12/31/1969
Nephrology and Hypertension Associates
mi
from
Bluefield, WV
Click here to add this to my saved trials
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated:  12/31/1969
West Virginia University
mi
from
Morgantown, WV
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated: 12/31/1969
West Virginia University
mi
from
Morgantown, WV
Click here to add this to my saved trials
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated:  12/31/1969
Aspirius Research Institute
mi
from
Wausau, WI
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated: 12/31/1969
Aspirius Research Institute
mi
from
Wausau, WI
Click here to add this to my saved trials
Reduction of Radiation Dose and Contrast Use During Cryoballoon Pulmonary Vein Isolation
Reduction of Radiation Dose and Contrast Use During Cryoballoon Pulmonary Vein Isolation
Status: Enrolling
Updated:  12/31/1969
University of Texas Southwestern
mi
from
Dallas, TX
Reduction of Radiation Dose and Contrast Use During Cryoballoon Pulmonary Vein Isolation
Reduction of Radiation Dose and Contrast Use During Cryoballoon Pulmonary Vein Isolation
Status: Enrolling
Updated: 12/31/1969
University of Texas Southwestern
mi
from
Dallas, TX
Click here to add this to my saved trials
Global Study to Assess the Safety and Effectiveness of Edoxaban (DU-176b) vs Standard Practice of Dosing With Warfarin in Patients With Atrial Fibrillation
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Multi-Center, Multi-National Study for Evaluation of Efficacy and Safety of Edoxaban (DU-176b) Versus Warfarin In Subjects With Atrial Fibrillation - Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation (ENGAGE - AF TIMI - 48)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Birmingham, AL
Global Study to Assess the Safety and Effectiveness of Edoxaban (DU-176b) vs Standard Practice of Dosing With Warfarin in Patients With Atrial Fibrillation
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Multi-Center, Multi-National Study for Evaluation of Efficacy and Safety of Edoxaban (DU-176b) Versus Warfarin In Subjects With Atrial Fibrillation - Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation (ENGAGE - AF TIMI - 48)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
Global Study to Assess the Safety and Effectiveness of Edoxaban (DU-176b) vs Standard Practice of Dosing With Warfarin in Patients With Atrial Fibrillation
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Multi-Center, Multi-National Study for Evaluation of Efficacy and Safety of Edoxaban (DU-176b) Versus Warfarin In Subjects With Atrial Fibrillation - Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation (ENGAGE - AF TIMI - 48)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Mobile, AL
Global Study to Assess the Safety and Effectiveness of Edoxaban (DU-176b) vs Standard Practice of Dosing With Warfarin in Patients With Atrial Fibrillation
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Multi-Center, Multi-National Study for Evaluation of Efficacy and Safety of Edoxaban (DU-176b) Versus Warfarin In Subjects With Atrial Fibrillation - Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation (ENGAGE - AF TIMI - 48)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Mobile, AL
Click here to add this to my saved trials
Global Study to Assess the Safety and Effectiveness of Edoxaban (DU-176b) vs Standard Practice of Dosing With Warfarin in Patients With Atrial Fibrillation
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Multi-Center, Multi-National Study for Evaluation of Efficacy and Safety of Edoxaban (DU-176b) Versus Warfarin In Subjects With Atrial Fibrillation - Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation (ENGAGE - AF TIMI - 48)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Gilbert, AZ
Global Study to Assess the Safety and Effectiveness of Edoxaban (DU-176b) vs Standard Practice of Dosing With Warfarin in Patients With Atrial Fibrillation
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Multi-Center, Multi-National Study for Evaluation of Efficacy and Safety of Edoxaban (DU-176b) Versus Warfarin In Subjects With Atrial Fibrillation - Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation (ENGAGE - AF TIMI - 48)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Gilbert, AZ
Click here to add this to my saved trials